Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Most women with excessive hair growth have a hormonal cause.

Auto-portraits help evaluate scalp hair.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Sebocytes play a key role in controlling androgen levels in human skin.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Lowering testosterone speeds up wound healing in male mice.

The document concludes that better biomarkers are needed to detect long-term oral testosterone use in athletes.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.